loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Mobocertinib NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Ash Stevens LLC (1)

filter

01 Mobocertinib (1)

filter

01 U.S.A (1)

URL Supplier Web Content
Mobocertinib
POWDER (1kg/kg)
BULK INGREDIENT
48957-0104
2021-09-15
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1847461-43-1 / Mobocertinib API manufacturers, exporters & distributors?

Mobocertinib manufacturers, exporters & distributors 1

74

PharmaCompass offers a list of Mobocertinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mobocertinib manufacturer or Mobocertinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mobocertinib manufacturer or Mobocertinib supplier.

PharmaCompass also assists you with knowing the Mobocertinib API Price utilized in the formulation of products. Mobocertinib API Price is not always fixed or binding as the Mobocertinib Price is obtained through a variety of data sources. The Mobocertinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Mobocertinib

Synonyms

1847461-43-1, Tak-788, Ap32788, Tak788, Mobocertinib [inn], Ap-32788

Cas Number

1847461-43-1

Unique Ingredient Identifier (UNII)

39HBQ4A67L

About Mobocertinib

Mobocertinib is an orally available inhibitor of human epidermal growth factor receptor (EGFR) exon 20 insertion mutations, with antineoplastic activity. Upon oral administration, mobocertinib, and its active metabolites, specifically and irreversibly binds to and inhibits exon 20 insertion mutations of EGFR. This prevents EGFR-mediated signaling and leads to cell death in tumor cells expressing exon 20 insertion mutations. In addition, mobocertinib may inhibit the activity of other EGFR family members, such as human epidermal growth factor receptor 2 (HER2; ERBB2) and HER4. EGFR, HER-2 and -4 are receptor tyrosine kinases often mutated in numerous tumor cell types. They play key roles in tumor cell proliferation and tumor vascularization.

Mobocertinib Manufacturers

A Mobocertinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mobocertinib, including repackagers and relabelers. The FDA regulates Mobocertinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mobocertinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Mobocertinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Mobocertinib Suppliers

A Mobocertinib supplier is an individual or a company that provides Mobocertinib active pharmaceutical ingredient (API) or Mobocertinib finished formulations upon request. The Mobocertinib suppliers may include Mobocertinib API manufacturers, exporters, distributors and traders.

click here to find a list of Mobocertinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Mobocertinib NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mobocertinib as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Mobocertinib API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Mobocertinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Mobocertinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mobocertinib NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Mobocertinib suppliers with NDC on PharmaCompass.

Mobocertinib Manufacturers | Traders | Suppliers

Mobocertinib Manufacturers, Traders, Suppliers 1
46

We have 1 companies offering Mobocertinib

Get in contact with the supplier of your choice:

  1. Ash Stevens, Inc.
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY